An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 021985
Company: NODEN PHARMA

Other Important Information from FDA

Products on NDA 021985

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TEKTURNA	ALISKIREN HEMIFUMARATE	EQ 150MG BASE	TABLET;ORAL	Prescription	AB	Yes	No
TEKTURNA	ALISKIREN HEMIFUMARATE	EQ 300MG BASE	TABLET;ORAL	Prescription	AB	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 021985

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/05/2007	ORIG-1	Approval	Type 1 - New Molecular Entity	STANDARD	Label (PDF) Letter (PDF) Review		https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021985lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021985s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021985s000TOC.cfm

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/17/2020	SUPPL-39	Labeling-Package Insert, Labeling-Patient Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021985s039lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/021985Orig1s039ltr.pdf
11/14/2017	SUPPL-34	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021985s034lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/021985Orig1s034ltr.pdf
11/04/2016	SUPPL-31	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021985s031lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/021985Orig1s031ltr.pdf
12/22/2015	SUPPL-28	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021985s028lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021985Orig1s028ltr.pdf
03/27/2015	SUPPL-27	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021985s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021985Orig1s027ltr.pdf
03/18/2014	SUPPL-26	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021985s026lbl.pdf
11/04/2013	SUPPL-25	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021985s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021985Orig1s025ltr.pdf
09/28/2012	SUPPL-24	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021985s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021985Orig1s024ltr.pdf
04/16/2012	SUPPL-23	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021985s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021985s023ltr.pdf
02/02/2012	SUPPL-22	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021985Orig1s022LBL.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021985s022ltrC.pdf
01/26/2012	SUPPL-21	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021985s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021985s021ltr.pdf
10/12/2011	SUPPL-19	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021985s019lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021985s019ltr.pdf
02/10/2011	SUPPL-14	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021985s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021985s014ltr.pdf
08/04/2010	SUPPL-12	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021985s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021985s012ltr.pdf
11/10/2009	SUPPL-8	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021985s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021985s008ltr.pdf
05/19/2008	SUPPL-6	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021985s006ltr.pdf
02/15/2008	SUPPL-4	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021985s004ltr.pdf
08/07/2007	SUPPL-2	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021985s002ltr.pdf

Labels for NDA 021985

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/17/2020	SUPPL-39	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021985s039lbl.pdf
06/17/2020	SUPPL-39	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021985s039lbl.pdf
11/14/2017	SUPPL-34	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021985s034lbl.pdf
11/04/2016	SUPPL-31	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021985s031lbl.pdf
12/22/2015	SUPPL-28	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021985s028lbl.pdf
03/27/2015	SUPPL-27	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021985s027lbl.pdf
03/18/2014	SUPPL-26	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021985s026lbl.pdf
11/04/2013	SUPPL-25	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021985s025lbl.pdf
09/28/2012	SUPPL-24	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021985s024lbl.pdf
04/16/2012	SUPPL-23	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021985s023lbl.pdf
02/02/2012	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021985Orig1s022LBL.pdf
01/26/2012	SUPPL-21	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021985s021lbl.pdf
10/12/2011	SUPPL-19	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021985s019lbl.pdf
02/10/2011	SUPPL-14	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021985s014lbl.pdf
08/04/2010	SUPPL-12	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021985s012lbl.pdf
11/10/2009	SUPPL-8	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021985s008lbl.pdf
03/05/2007	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021985lbl.pdf

Therapeutic Equivalents for NDA 021985

TEKTURNA

TABLET;ORAL; EQ 150MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ALISKIREN HEMIFUMARATE	ALISKIREN HEMIFUMARATE	EQ 150MG BASE	TABLET;ORAL	Prescription	No	AB	206665	ANCHEN PHARMS
TEKTURNA	ALISKIREN HEMIFUMARATE	EQ 150MG BASE	TABLET;ORAL	Prescription	Yes	AB	021985	NODEN PHARMA

TABLET;ORAL; EQ 300MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ALISKIREN HEMIFUMARATE	ALISKIREN HEMIFUMARATE	EQ 300MG BASE	TABLET;ORAL	Prescription	No	AB	206665	ANCHEN PHARMS
TEKTURNA	ALISKIREN HEMIFUMARATE	EQ 300MG BASE	TABLET;ORAL	Prescription	Yes	AB	021985	NODEN PHARMA

Top